T. Harrison (Nottingham (Nottinghamshire), United Kingdom), V. Backer (Copenhagen, Denmark), S. Fowler (Preston (Lancashire), United Kingdom), A. Menzies-Gow (London, United Kingdom)
Refractory Asthma in Qena Governorate: Egypt a single center study
M. Shahat Badawy (qena, Egypt), A. Rashad (qena, Egypt), E. Mohamed (qena, Egypt), M. Mohamed (qena, Egypt)
|   |
Sub-optimal asthma control with medium- or high-dose ICS/LABA: a retrospective cohort study from Japan claims database
H. Inoue (Kagoshima, Japan), K. Milligan (Tokyo, Japan), A. Mcconnon (Dublin, Ireland), H. Yoshisue (Tokyo, Japan), E. Loefroth (Kista, Sweden), M. Mcsharry (Dublin, Ireland), A. Yokoyama (Kochi, Japan), M. Ichinose (Sendai, Japan)
| |
Difference in asthma control levels by assessment tools: Observational study
T. Iwanaga (Osakasayama, Japan), H. Tanaka (Sapporo, Japan), S. Hozawa (Hiroshima, Japan), Y. Tohda (Osakasayama, Japan)
| |
Use of short-acting beta-2 agonists (SABA) and exacerbations in a nationwide Swedish asthma cohort (HERA)
C. Janson (Uppsala, Sweden), B. Nwaru (Lund, Sweden), L. Hasvold (Sodertalje, Sweden), F. Wicklund (Uppsala, Sweden), G. Telg (Sodetalje, Sweden), M. Ekstrom (Gothenburg, Sweden)
| |
Can high doses of inhaled corticosteroids increase the level of total serum cholesterol?: a retrospective cohort study.
A. Sánchez Azofra (Madrid, Spain), C. Cisneros Serrano (Madrid, Spain), B. Aldave Orzaiz (Madrid, Spain), E. Ávalos Pérez-Urria (Madrid, Spain), A. Martínez Meca (Madrid, Spain), C. Acosta Gutierrez (Madrid, Spain), A. Martinez Vergara (Madrid, Spain), M. Erro Iribarren (Madrid, Spain), A. Roca Noval (Madrid, Spain), M. Sanz Pastor (Madrid, Spain), J. Soriano (Madrid, Spain), J. Ancochea Bermúdez (Madrid, Spain)
| |
Prevalence of the use of oral corticosteroids in asthma – a 3-year analysis in Germany
M. Lommatzsch (Rostock, Germany), C. Wilmer (Nürnberg, Germany), I. Schwab Sauerbeck (Nürnberg, Germany)
| |
Oral corticosteroid prescription patterns in asthma care in Italy
T. Tran (Gaithersburg, United States of America), E. King (London, United Kingdom), R. Sarkar (Bengaluru, India), C. Nan (Cambridge, United Kingdom), A. Rubino (London, United Kingdom), C. O'Leary (London, United Kingdom), L. Belton (Cambridge, United Kingdom), J. Quint (London, United Kingdom)
| |
Evaluating inhaled corticosteroid use among pregnant women with asthma: systematic review and meta-analysis
A. Robijn (New Lambton Heights, Australia), M. Jensen (New Lambton Heights, Australia), K. Mclaughlin (New Lambton Heights, Australia), P. Gibson (New Lambton Heights, Australia), V. Murphy (New Lambton Heights, Australia)
| |
Montelukast and cardiovascular events: Insights from observational retrospective study
M. Hoxha (Tirana, Albania), V. Malaj (Tirana, Albania), S. Quaglini (Pavia, Italy), V. Capra (Milan, Italy), J. Evans (Philadelphia, United States of America), A. Sala (Milan, Italy), G. Rovati (Milan, Italy)
| |
Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis
D. Tan (Melbourne, Australia), D. Bui (Melbourne, Australia), X. Dai (Melbourne, Australia), C. Lodge (Melbourne, Australia), A. Lowe (Melbourne, Australia), P. Thomas (Sydney, Australia), M. Abramson (Melbourne, Australia), H. Walters (Hobart, Australia), J. Perret (Melbourne, Australia), S. Dharmage (Melbourne, Australia)
| |
Characterizing healthcare resource utilization by GINA steps in asthma patients
W. Busse (Madison, WI, United States of America), J. Fang (East Hanover, NJ, United States of America), J. Marvel (East Hanover, NJ, United States of America), H. Tian (Morristown, NJ, United States of America), P. Altman (East Hanover, NJ, United States of America), H. Cao (East Hanover, NJ, United States of America)
| |
Difficult asthma and obesity
N. Fahem (Monastir, Tunisia), L. Loued (Monastir, Tunisia), A. Ben Saad (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), S. Cheikh Mhamed (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia)
| |
Antibiotics use for asthma exacerbation in Japanese geriatric patients
Y. Fukuda (Tokyo, Japan), T. Homma (Tokyo, Japan), A. Tanaka (Tokyo, Japan), H. Sagara (Tokyo, Japan)
| |
Oral corticosteroid use in Swedish and Finnish severe asthma patients
K. Geale (Stockholm, Sweden), H. Darabi (Stockholm, Sweden), M. Lindh (Stockholm, Sweden), L. Alvares (Basel, Switzerland), R. Dodge (Copenhagen, Denmark), A. Altraja (Tartu, Estonia), V. Backer (Copenhagen, Denmark), L. Bjermer (Lund, Sweden), A. Bossios (Stockholm, Sweden), C. Janson (Uppsala, Sweden), H. Kankaanranta (Seinäjoki, Finland), P. Kauppi (Helsinki, Finland), L. Lehtimäki (Tampere, Finland), C. Suppli Ulrik (Copenhagen, Denmark), A. Viinanen (Turku, Finland), C. Porsbjerg (Copenhagen, Denmark)
| |
SABA and ICS use among mild asthma patients in UK primary care
C. Bloom (London, United Kingdom), J. Quint (London, United Kingdom), C. Cabrera (Gothenburg, Sweden)
| |
Asthma control (AC) in the adult population from Kuwait: ESMAA study
N. Behbehani (Kuwait City, Kuwait), M. Al-Ahmad (Kuwait City, Kuwait), S. Al-Mutairi (Kuwait City, Kuwait), S. Al-Mutairi (Kuwait City, Kuwait), A. Al-Saeedi (Kuwait City, Kuwait), H. Farouk (Dubai, United Arab Emirates), A. Adel (Dubai, United Arab Emirates), F. Montestruc (Malakoff, France), M. Al-Shammari (Kuwait City, Kuwait)
| |
Evaluation of asthma control and quality of life after 6 months of treatment with FDC Budesonide/Formoterol-BOREAS study.
P. Bakakos (Athens, Greece), D. Papakosta (Thessaloniki, Greece), E. Zervas (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), A. Ginis (Attica, Greece), M. Bertoli (Attica, Greece), K. Apostolidou (Attica, Greece), S. Loukides (Athens, Greece)
| |
Asthma control and quality of life in asthmatic patients treated for 6 months with FDC Budesonide/Formoterol - BOREAS study: a subgroup analysis in patients with comorbidities
D. Papakosta (Thessaloniki, Greece), S. Loukides (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), E. Zervas (Athens, Greece), K. Apostolidou (Attica, Greece), M. Bertoli (Attica, Greece), A. Ginis (Attica, Greece), P. Bakakos (Athens, Greece)
| |
How common is stepping-down asthma treatment in England?
C. Bloom (London, United Kingdom), J. Quint (London, United Kingdom)
| |
Pulmonary function improvement in patients with asthma during GINA implementation: a 5-year observational follow-up study
T. Nguyen (Ho Chi Minh, Vietnam), Q. Vu (Ho Chi Minh, Vietnam), L. Le (Ho Chi Minh, Vietnam)
| |